Overview
Nando’s is a biotechnology company that develops and manufactures microbiological products and chemical additives for agriculture and industry, including biostimulants, surfactants, and other additives. Its products are created through biotechnology, chemistry, and engineering at one of Northern Europe’s largest R&D centers, with collaborations worldwide to test and improve them. The company differentiates itself through a strong in-house R&D program and university partnerships, offering a broad portfolio of high-added-value solutions rather than generic products. Its goal is to bring science-driven products to market that improve crop and livestock production and support industrial processes globally.
Work here?Claim your company
Simplify's take
What believers are saying
- Nando's opened 34 restaurants in 2025, including 11 in the UK and Ireland.
- Management plans 15 more UK and Ireland openings, supported by £116.6 million investment.
- Energy-efficient grills and menu innovation protect demand while lowering operating costs.
What critics are saying
- November 4, 2026 accounts showed an £11.3 million loss after £38.2 million profit.
- Rising energy, labour, and food costs threaten margins despite 2% revenue growth to £1.51 billion.
- A June 2026 alleged breach exposed 87,000 employee records, risking trust and regulatory damage.
What makes Nando's unique
- Nando's hit 500 UK and Ireland restaurants on April 29, 2026.
- Its Southern African design, heritage branding, and PERi-PERi menu create strong identity.
- The chain pairs dine-in, takeaway, Click and Collect, and drive-thru experimentation.
Help us improve and share your feedback! Did you find this helpful?